Trial Profile

A phase 2 study of LNK01003 in Patients with Ulcerative Colitis

Status: Recruiting

Phase of Trial: Phase II

Latest Information Update: 06 Apr 2023

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs LNK 01003 (Primary)
Indications Ulcerative colitis
Focus Adverse reactions; Therapeutic Use
Sponsors Lynk Pharmaceuticals

Most Recent Events

04 Apr 2023 According to a Lynk Biotechnologies media release, this study received supports from multiple excellent clinical centers across the country.
07 Dec 2022 New trial record
05 Dec 2022 According to a Lynk Biotechnologies media release, Professor Minhu Chen, director of the Chinese Medical Association's Society of Gastroenterology, and chief physician of The First Affiliated Hospital of Sun Yat Sen University is the principle investigator in the trial.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com